Third Orthopaedic and Traumatologic Clinic, Sports Traumatology Department, Istituto Ortopedico Rizzoli, Bologna, Italy.
Am J Sports Med. 2012 Feb;40(2):395-403. doi: 10.1177/0363546511424688. Epub 2011 Nov 4.
Meniscal allograft transplantation is a viable option for subtotally meniscectomized and totally meniscectomized symptomatic patients and potentially results in pain relief and increased function.
The use of a single tibial tunnel arthroscopic technique without bone plugs will reduce symptoms (pain) and improve knee function at a minimum 3-year follow-up.
Case series; Level of evidence, 4.
Thirty-two meniscal transplantations (16 medial, 16 lateral; 23 men, 9 women) were prospectively evaluated at a minimum of 36 months (mean, 40.4 ± 6.90 months; range, 36-66 months) after surgery. The average age at the time of surgery was 35.6 ± 10.3 years (range, 15-55 years). The transplantation was performed using an arthroscopic bone plug-free technique with a single tibial tunnel plus "all-inside" meniscal sutures. The anterior meniscal horn was sutured to the capsule. Follow-up included a visual analog scale (VAS) score for knee pain and subjective and objective International Knee Documentation Committee (IKDC), Lysholm, Tegner, and SF-36 scores. All patients underwent radiographic and magnetic resonance imaging (MRI) evaluation of the involved knee before the surgery and at the final follow-up. The MRI outcomes were evaluated with the modified Yulish score.
Regarding clinical evaluation, there was a significant improvement in scores at follow-up compared with preoperatively: the VAS score decreased from 70.6 ± 21.7 to 25.2 ± 22.7 (P < .0001), the SF-36 physical component score increased from 37.31 ± 7.2 to 49.69 ± 8.3 (P < .0001), the SF-36 mental component score increased from 49.69 ± 10.8 to 53.53 ± 7.5 (P = .0032), the Tegner activity score increased from 3 (range, 3-5) to 5 (range, 3-6) (P < .0121), the Lysholm score increased from 59.78 ± 18.25 to 84.84 ± 14.4 (P < .0001), the subjective IKDC score increased from 47.44 ± 20.60 to 77.20 ± 15.57 (P < .0001), and the objective IKDC score changed from 1 A, 21 B, 6 C, and 4 D to 22 A, 9 B, and 1 C (P < .0001). No significant difference was found in this study between patients who received medial allografts and patients who received lateral allografts. There was no significant difference between outcomes of patients with isolated and combined procedures. The MRI findings showed 69% extruded allografts (8 medial and 14 lateral). In detail, we found 50% of the medial allografts and 87% of the lateral allografts extruded. No significant difference in clinical outcomes and modified Yulish score was found between patients with extruded allografts and with in situ allografts. The MRI results also showed a significant decrease of the modified Yulish score from baseline to 3-year minimum follow-up (P < .0001 for femur and P < .0001 for tibia). Only one patient underwent arthroscopic selective meniscectomy because of a medial posterior horn retear of the graft. One patient developed lack of flexion and underwent an arthroscopic arthrolysis. These 2 patients did not draw benefit from allografting and therefore were considered failures. In all remaining cases (94%), meniscal allograft transplantation was able to reduce symptoms (pain measured by VAS) and improve knee function (as measured by IKDC and Lysholm scores).
This study found that a single tibial tunnel arthroscopic technique without bone plugs for meniscal allograft transplantation significantly reduced pain and improved knee function in 94% of patients at a minimum 3-year follow-up.
半月板同种异体移植术是一种可行的选择,适用于部分半月板切除和全半月板切除的有症状患者,可能会缓解疼痛并增加功能。
使用无骨栓的单胫骨隧道关节镜技术可减少症状(疼痛)并在至少 3 年的随访中改善膝关节功能。
病例系列;证据水平,4 级。
32 例半月板移植(16 例内侧,16 例外侧;23 例男性,9 例女性)在手术后至少 36 个月(平均 40.4±6.90 个月;范围 36-66 个月)时进行前瞻性评估。手术时的平均年龄为 35.6±10.3 岁(范围 15-55 岁)。移植采用关节镜下无骨栓技术,单胫骨隧道加“全内”半月板缝合。前半月板角缝合到囊。随访包括膝关节疼痛的视觉模拟量表(VAS)评分以及国际膝关节文献委员会(IKDC)、Lysholm、Tegner 和 SF-36 评分的主观和客观评分。所有患者在手术前和最后一次随访时均进行了受累膝关节的放射学和磁共振成像(MRI)评估。使用改良 Yulish 评分评估 MRI 结果。
在临床评估方面,与术前相比,随访时的评分有显著改善:VAS 评分从 70.6±21.7 降至 25.2±22.7(P<.0001),SF-36 生理成分评分从 37.31±7.2 增至 49.69±8.3(P<.0001),SF-36 心理成分评分从 49.69±10.8 增至 53.53±7.5(P=.0032),Tegner 活动评分从 3(范围 3-5)增至 5(范围 3-6)(P<.0121),Lysholm 评分从 59.78±18.25 增至 84.84±14.4(P<.0001),主观 IKDC 评分从 47.44±20.60 增至 77.20±15.57(P<.0001),客观 IKDC 评分从 1 A、21 B、6 C 和 4 D 变为 22 A、9 B 和 1 C(P<.0001)。本研究中,接受内侧同种异体移植物和接受外侧同种异体移植物的患者之间没有发现明显差异。孤立性和联合手术的结果之间也没有显著差异。MRI 结果显示 69%的同种异体移植物突出(8 个内侧和 14 个外侧)。具体来说,我们发现 50%的内侧同种异体移植物和 87%的外侧同种异体移植物突出。在有突出同种异体移植物和原位同种异体移植物的患者中,临床结果和改良 Yulish 评分没有显著差异。MRI 结果还显示,从基线到 3 年最低随访时,改良 Yulish 评分显著下降(股骨 P<.0001,胫骨 P<.0001)。只有 1 例患者因移植物内侧后角撕裂而接受关节镜下选择性半月板切除术。1 例患者出现屈曲受限,并接受了关节镜下关节松解术。这 2 例患者没有从同种异体移植中获益,因此被认为是失败的。在所有其余病例(94%)中,半月板同种异体移植能够减轻疼痛(通过 VAS 测量的疼痛)并改善膝关节功能(通过 IKDC 和 Lysholm 评分测量)。
本研究发现,对于半月板同种异体移植术,使用无骨栓的单胫骨隧道关节镜技术可显著减少 94%患者的疼痛,并在至少 3 年的随访中改善膝关节功能。